# Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection

> **NCT05545137** · PHASE3 · COMPLETED · sponsor: **Benova (Tianjin) Innovative medicine Research Co., Ltd.** · enrollment: 299 (actual)

## Conditions studied

- Uncomplicated Urinary Tract Infection

## Interventions

- **DRUG:** Pivmecillinam hydrochloride tablets
- **DRUG:** Fosfomycin Tromethamine Granules

## Key facts

- **NCT ID:** NCT05545137
- **Lead sponsor:** Benova (Tianjin) Innovative medicine Research Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-29
- **Primary completion:** 2024-02-05
- **Final completion:** 2024-02-20
- **Target enrollment:** 299 (ACTUAL)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05545137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05545137, "Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05545137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*